Regulatory Impact Analysis on Cannabis approved
Approved by Anvisa’s Dicol, the Regulatory Impact Analysis (RIA) report on cannabis products offers a comprehensive assessment of the regulatory scenario for medicinal cannabis in Brazil, suggesting improvements to the current regulations.
If you need more information on regulatory issues, ELS can certainly help.
ontact your local ELS consultant or via email info@elssolutions.pt
